Long-Term Treatment with Eicosapentaenoic Acid Augments Both Nitric Oxide-Mediated and Non-Nitric Oxide-Mediated Endothelium-Dependent Forearm Vasodilatation in Patients with Coronary Artery Disease
Authors:
- Hiroaki ShimokawaHSHiroaki Shimokawa
- Tatsuya TagawaTTTatsuya Tagawa
- Mari Kuroiwa-MatsumotoMKMari Kuroiwa-Matsumoto
- Yoshitaka HirookaYHYoshitaka Hirooka
- Akira TakeshitaATAkira Takeshita
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 33 (4) , 633-640
Abstract
Long-term treatment with eicosapentaenoic acid (EPA) is known to improve impaired endothelium-dependent relaxations of atherosclerotic blood vessels in animals and humans. However, it remains to be determined which mechanisms are involved in this beneficial effect of EPA. In this study, we investigated our hypothesis that EPA improves both nitric oxide (NO)-mediated and non-NO-mediated endothelium-dependent vasodilatation in patients with coronary artery disease. The study included eight patients with documented coronary artery disease. The forearm vascular responses to the endothelium-dependent vasodilator acetylcholine and substance P were examined before and after intraarterial infusion of N G-monomethyl-L-arginine (L-NMMA). Same measurements were repeated after the treatment with EPA (1,800 mg/day) for 6 weeks. The long-term treatment with EPA augmented forearm blood-flow response to both acetylcholine and substance P. Furthermore, acute administration of L-NMMA significantly inhibited the EPA-induced augmented response to acetylcholine but not that to substance P. The forearm vascular response to sodium nitroprusside was unchanged by the EPA treatment. These results indicate that long-term treatment with EPA augments both NO-dependent and non-NO-dependent endothelium-dependent forearm vasodilatation in patients with coronary artery disease. Thus the beneficial effects of EPA appear to extend to non-NO-dependent mechanism(s).Keywords
This publication has 27 references indexed in Scilit:
- Fish Consumption and the 30-Year Risk of Fatal Myocardial InfarctionNew England Journal of Medicine, 1997
- Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: Role of cyclooxygenase products and endothelium-derived relaxing factorThrombosis Research, 1994
- Fish Oil, Atherogenesis, and ThrombogenesisaAnnals of the New York Academy of Sciences, 1994
- Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein.Circulation, 1991
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- Computer-detected ventricular tachycardia in the coronary care unit: prognosis in patients with and without acute myocardial infarctionJournal of Internal Medicine, 1989
- Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusionAmerican Heart Journal, 1988
- Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries.Circulation, 1987
- Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.Circulation, 1983
- EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS?The Lancet, 1978